The bioT3 Platform

Ralph V. Boccia, MD, FACP

Video Categories: PMO Interview with the Innovator Series: Volume 9

Dr. Boccia describes the components of the bioT3 platform and its clinical utility in identifying tumor type and actionable targets for therapy.
October 1, 2014

The Changing Role of Pharmacists

Hear Atheer Kaddis describe how the role of the pharmacist is changing in hematology and oncology.Supported through funding from Incyte

January 10, 2019

Immunotherapy vs Targeted Therapy

Dr Morganna Freeman explains the difference between immunotherapies and targeted therapies in plain language for patients to easily understand.